LIVER DISEASES
Clinical trials for LIVER DISEASES explained in plain language.
Never miss a new study
Get alerted when new LIVER DISEASES trials appear
Sign up with your email to follow new studies for LIVER DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Liver pressure drug trial halted early – what we know
Disease control TerminatedThis study tested a new medicine called Avenciguat (BI 685509) to lower high blood pressure in the liver's main vein, a condition called portal hypertension, in people with compensated cirrhosis. About 90 adults with cirrhosis from hepatitis B, C, or NASH took the drug alone or w…
Matched conditions: LIVER DISEASES
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Blood test holds promise for early liver cancer detection
Diagnosis TerminatedThis study looked at whether tiny bits of genetic material (extracellular RNA) found in the blood can help doctors diagnose liver cancer or other liver diseases. Researchers planned to enroll about 1,865 people with liver cancer, bile duct cancer, cirrhosis, or chronic liver dise…
Matched conditions: LIVER DISEASES
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 11, 2026 20:52 UTC
-
Real-World hepatitis b study aims to track patient outcomes
Knowledge-focused TerminatedThis study observed over 1,700 adults with chronic hepatitis B at regular clinics in the US and Canada. Researchers collected information on how the disease progresses, which treatments are used, and how well they work. The goal was to learn more about the real-world management a…
Matched conditions: LIVER DISEASES
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 05:32 UTC